首页> Oncoimmunology> PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab.

PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab.

导出 LinkOut

翻译打印收藏纠错

第一作者： Gabriele,Madonna

第一单位： Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy.

作者： Gabriele,Madonna ^[1] ; Carmen,Ballesteros-Merino ^[2] ; Zipei,Feng ^[3] ; Carlo,Bifulco ^[4] ; Mariaelena,Capone ^[1] ; Diana,Giannarelli ^[5] ; Domenico,Mallardo ^[1] ; Ester,Simeone ^[1] ; Antonio M,Grimaldi ^[1] ; Corrado,Caracò ^[6] ; Gerardo,Botti ^[7] ; Bernard A,Fox ^[8] ; Paolo A,Ascierto ^[1]

作者单位： Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. ^[1] Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. ^[2] Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA.;Department of Cancer Biology, Oregon Health & Science University, Portland, OR, USA. ^[3] Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA.;Department of Pathology, Providence Portland Medical Center, Portland, OR, USA. ^[4] Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy. ^[5] Melanoma and Sarcoma Surgery Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. ^[6] Unit of Pathology, IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. ^[7] Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA.;Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, USA. ^[8]

关键词 Immunotherapy Ipilimumab Melanoma PD-L1 Tumor microenvironment

DOI 10.1080/2162402X.2017.1405206

PMID 30524879

发布时间 2021-01-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交